| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MXCT | Common Stock | Options Exercise | $19.7K | +23.4K | $0.84 | 23.4K | Nov 1, 2022 | Direct | F1 | |
| transaction | MXCT | Common Stock | Sale | -$163K | -23.4K | -100% | $6.94 | 0 | Nov 1, 2022 | Direct | F1, F2 |
| transaction | MXCT | Common Stock | Options Exercise | $3.73K | +4.44K | $0.84 | 4.44K | Nov 2, 2022 | Direct | F1 | |
| transaction | MXCT | Common Stock | Options Exercise | $1.37K | +1.27K | +28.53% | $1.08 | 5.7K | Nov 2, 2022 | Direct | F1, F3 |
| transaction | MXCT | Common Stock | Sale | -$39.1K | -5.7K | -100% | $6.85 | 0 | Nov 2, 2022 | Direct | F1, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MXCT | Employee Stock Option (right to buy) | Options Exercise | $0 | -23.4K | -84.07% | $0.00 | 4.44K | Nov 1, 2022 | Common Stock | 23.4K | $0.84 | Direct | F1, F5 |
| transaction | MXCT | Employee Stock Option (right to buy) | Options Exercise | $0 | -4.44K | -100% | $0.00* | 0 | Nov 2, 2022 | Common Stock | 4.44K | $0.84 | Direct | F1, F5 |
| transaction | MXCT | Employee Stock Option (right to buy) | Options Exercise | $0 | -1.27K | -2.04% | $0.00 | 60.7K | Nov 2, 2022 | Common Stock | 1.27K | $1.08 | Direct | F1, F3, F5 |
| Id | Content |
|---|---|
| F1 | The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022. |
| F2 | The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.80 to $7.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F3 | This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant. |
| F4 | The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.72 to $6.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F5 | This option is fully vested and exercisable. |